Dynamic changes of serum metabolites associated with infection and severity of patients with acute hepatitis E infection
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27669
Abstract: Dynamic changes in metabolites may affect liver disease progression, and provide new methods for predicting liver damage. We used ultra‐performance liquid chromatography–mass spectroscopy to assess serum metabolites in healthy controls (HC), and patients with acute… read more here.
Keywords: serum metabolites; ahe patients; infection; hev alf ... See more keywords
The diagnostic and prognostic value of serum exosome‐derived carbamoyl phosphate synthase 1 in HEV‐related acute liver failure patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27961
Abstract: Early diagnosis and prognosis evaluation are of great significance to hepatitis E virus (HEV)‐related acute liver failure (HEV‐ALF) patients. We collected serum samples from 200 health controls (HCs), 200 patients with acute hepatitis E (AHE),… read more here.
Keywords: serum exosome; hev alf; exosome derived; derived cps1 ... See more keywords
Serum extracellular vesicle‐derived ASS1 is a promising predictor for the occurrence of HEV‐ALF
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28425
Abstract: Development of biomarkers for predicting the occurrence of hepatitis E virus related‐acute liver failure (HEV‐ALF) is conducive to prevention and early intervention. Serum samples from 250 HEV‐ALF patients, 250 patients with acute hepatitis E (AHE)… read more here.
Keywords: occurrence; derived ass1; hev alf; serum ... See more keywords